Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRX-08066 in Pulmonary Hypertension and COPD
NCT00345774Phase 2Completed
- Sponsor
- Epix Pharmaceuticals
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of prx-08066 in pulmonary hypertension (PH), sponsored by Epix Pharmaceuticals. Started Jun 2006; status: completed.
02
Drugs
prx-08066
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT00345774.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00345774.